Zobrazeno 1 - 1
of 1
pro vyhledávání: '"Tiying Deng"'
Publikováno v:
Frontiers in Pharmacology, Vol 15 (2024)
BackgroundInhibitors of the anaplastic lymphoma kinase (ALK) gene mutation are first-line treatments in patients with ALK-positive lung cancer. The FDA label warns of the risk of interstitial lung disease (ILD) in patients receiving ALK TKIs. However
Externí odkaz:
https://doaj.org/article/de1bea835ce7457f820904a608365a79
